E Jr Biography and Net Worth

Director of SiBone

Timothy (Ted) E. Davis, Jr. has served as a member of our board of directors since our inception in April 2008. Mr. Davis joined BioTissue Holdings Inc. (fka BioTissue,Inc.), a market leader in regenerative therapies for treating the ocular surface and other surgical indications, as President and Chief Executive Officer in January 2022. He previously served as President and Chief Executive Officer of Active Implants, LLC, a company focused on the knee preservation segment of sports medicine from 2017 through 2021. From January 2014 through September 2015, Mr. Davis served as Chief Executive Officer of MicroPort Orthopedics, Inc., following the purchase of Wright Medical Group’s OrthoRecon Business in January 2014. From December 2006 to January 2014, Mr. Davis served in a number of executive positions for Wright Medical Technology, Inc., a subsidiary of Wright Medical Group, Inc., including President of the OrthoRecon business. From 2004 to 2006, Mr. Davis was a Partner with MB Venture Partners, LLC, a medical technology and life sciences venture capital firm. From 1997 to 2004, Mr. Davis held various positions, ultimately serving as Vice President, with Vector Fund Management, a healthcare and life sciences focused venture capital fund. Early in his career, Mr. Davis worked in the healthcare management consulting and pharmaceutical industries. Mr. Davis received a B.E. degree in Biomedical Engineering from Vanderbilt University and an M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University.

What is E Davis Jr's net worth?: The estimated net worth of E Davis Jr is at least $430.23 thousand as of January 2nd, 2024. Jr owns 22,361 shares of SiBone stock worth more than $430,226 as of December 5th. This net worth evaluation does not reflect any other investments that Jr may own. Learn More about E Davis Jr's net worth.
How do I contact E Davis Jr?: The corporate mailing address for Jr and other SiBone executives is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. SiBone can also be reached via phone at (408) 207-0700 and via email at [email protected]. Learn More on E Davis Jr's contact information.
Has E Davis Jr been buying or selling shares of SiBone?: E Davis Jr has not been actively trading shares of SiBone within the last three months. Most recently, Timothy E. Davis, Jr. sold 9,900 shares of the business's stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $20.93, for a transaction totalling $207,207.00. Following the completion of the sale, the director now directly owns 22,361 shares of the company's stock, valued at $468,015.73. Learn More on E Davis Jr's trading history.
Who are SiBone's active insiders?: SiBone's insider roster includes Jeffrey Dunn (Director), Laura Francis (CEO), John Freund (Director), Jeryl Hilleman (Director), Gregory Hinckley (Director), E Jr (Director), Anshul Maheshwari (CFO), Mika Nishimura (Director), Michael Pisetsky (SVP), and Anthony Recupero (Insider). Learn More on SiBone's active insiders.
Are insiders buying or selling shares of SiBone?: In the last year, insiders at the sold shares 41 times. They sold a total of 278,971 shares worth more than $4,941,347.88. The most recent insider tranaction occured on November, 25th when CFO Anshul Maheshwari sold 100 shares worth more than $2,000.00. Insiders at SiBone own 4.0% of the company. Learn More about insider trades at SiBone.
Information on this page was last updated on 11/25/2025.

E Davis Jr Insider Trading History at SiBone

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/2/2024	Sell	9,900	$20.93	$207,207.00	22,361

E Davis Jr Buying and Selling Activity at SiBone

SiBone Company Overview

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Today's Range

Now: $19.24

$18.99

$19.61

50 Day Range

MA: $16.42

$14.05

$19.67

2 Week Range

Now: $19.24

$12.49

$20.05

Volume

532,706 shs

Average Volume

708,957 shs

Market Capitalization

$834.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76